BRIEF-Biogen’s Imraldi granted positive opinion by committee for medicinal products for human use
* Biogen’s Imraldi, an adalimumab biosimilar candidate referencing Humira, granted positive opinion by committee for medicinal products for human use
Singapore is close to signing a deal worth up to $2.43 billion with the United States to modernise its entire fleet of 60 F-16 fighter jets.
The investment, if it happens, will be the largest and most ambitious yet in the 45-year history of the Republic of Singapore Air Force, it is believed.
NOTE: Reuters has not verified this story and does not vouch for its accuracy.
* Indexes down: Dow 0.22 pct, S&P 0.09 pct, Nasdaq 0.25 pct (Updates to open)